Letter Regarding "Prescribing SGLT2 Inhibitors in Patients With CKD: Expanding Indications and Practical Considerations"
Kidney Int Rep
.
2022 Aug 28;7(11):2545-2546.
doi: 10.1016/j.ekir.2022.08.017.
eCollection 2022 Nov.
Authors
Jorge Rico-Fontalvo
1
,
Jose Cabrales
2
,
Tomás Rodriguez-Yanez
3
,
Rodrigo Daza-Arnedo
1
Affiliations
1
Colombian Association of Nephrology, Colombia.
2
Stanford University School of Medicine, Palo Alto, California, USA.
3
Internal Medicine, University Cartagena. Cartagena, Colombia.
PMID:
36531869
PMCID:
PMC9751679
DOI:
10.1016/j.ekir.2022.08.017
No abstract available